Skip to main content
Livermore
Livermore
ZHEN

Hepion Pharmaceuticals, Inc.

HEPA
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001583771

In the last 90 days, Hepion Pharmaceuticals, Inc. insiders filed 5 open-market purchases and 0 sales; 1 institution reported holding it in 13F filings for Q2 2026, worth $0 in total; no superinvestor holds it.

Other share classesCTRVP

Holders of 5% or more of HEPA

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Hepion Pharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of HEPA
HolderLatest formStakeChangeFirst filedLatest filingFiling
LoPriore Vincent S13D/A26.20%26.3M shares+4.74 ppfrom 21.46%May 1, 20262 filingsAug 20, 2026SEC
Black Global 5 LLC13D11.10%10.0M sharesNewAug 7, 20261 filingAug 7, 2026SEC
KI Holdings, Ltd.13D/A10.20%10.0M shares–Sep 16, 20261 filingSep 16, 2026SEC
Bigger Capital Fund L P13G9.99%1.06M sharesNewJan 24, 20251 filingJan 24, 2025SEC
Rickel Kenneth13G5.70%5.25M sharesNewSep 15, 20261 filingSep 15, 2026SEC
Appajosyula Sireesh13D5.70%5.25M sharesNewAug 20, 20261 filingAug 20, 2026SEC
Stetz Gary S.13D5.70%5.25M sharesNewAug 20, 20261 filingAug 20, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

26 Schedule 13D and 13G filings on Hepion Pharmaceuticals, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on HEPA
Filed (ET)FilerFormStakeChangeEvent dateFiling
Sep 16, 20264:15 PM ETKI Holdings, Ltd.13D/A10.20%10.0M shares–Aug 3, 2026SEC
Sep 15, 20265:30 PM ETRickel Kenneth13G5.70%5.25M sharesNewAug 3, 2026SEC
Aug 20, 20264:30 PM ETLoPriore Vincent Sand 2 others13D/A26.20%26.3M shares+4.74 ppfrom 21.46%Aug 3, 2026SEC
Aug 20, 20264:30 PM ETAppajosyula Sireesh13D5.70%5.25M sharesNewAug 3, 2026SEC
Aug 20, 20264:30 PM ETStetz Gary S.13D5.70%5.25M sharesNewAug 3, 2026SEC
Aug 7, 20262:02 PM ETBlack Global 5 LLCand 2 others13D11.10%10.0M sharesNewJul 31, 2026SEC
May 1, 20265:28 PM ETLoPriore Vincent Sand 2 others13D21.46%6.25M sharesNewApr 21, 2026SEC
Aug 14, 20259:41 PM ETAnson Funds Management LPand 5 others13G/A4.90%576.5K shares−5.00 ppfrom 9.90%Below 5%Jun 30, 2025SEC
Aug 14, 20256:45 PM ETS.H.N. Financial Investments Ltd.13G/A0.00%0 shares−9.99 ppfrom 9.99%Below 5%Aug 14, 2025SEC
May 15, 20255:23 PM ETAnson Funds Management LPand 5 others13G9.90%595.7K sharesNewMar 31, 2025SEC
Jan 27, 20254:15 PM ETS.H.N. Financial Investments Ltd.13G9.99%1.06M sharesNewJan 22, 2025SEC
Jan 24, 20258:32 PM ETBigger Capital Fund L Pand 2 others13G9.99%1.06M sharesNewJan 21, 2025SEC
Nov 14, 2024Armistice Capital, LLC13G/AOld format–––SEC
Feb 14, 2024Armistice Capital, LLC13GOld format–New–SEC
Feb 14, 2022Altium Capital Management LP13G/AOld format–––SEC
Feb 10, 2022Vanguard Group Inc13G/AOld format–––SEC
Jan 19, 2022Empery Asset Management, LP13G/AOld format–––SEC
Jan 4, 2022Sabby Management, LLC13G/AOld format–––SEC
Feb 24, 2021Altium Capital Management LP13GOld format–New–SEC
Feb 19, 2021Sabby Management, LLC13GOld format–––SEC
Feb 18, 2021Empery Asset Management, LP13GOld format–––SEC
Feb 16, 2021CVI Investments, Inc.13G/AOld format–––SEC
Feb 10, 2021Vanguard Group Inc13GOld format–New–SEC
Feb 9, 2021Hudson Bay Capital Management LP13G/AOld format–––SEC
Jan 20, 2021Empery Asset Management, LP13G/AOld format–––SEC
Jan 7, 2021Sabby Management, LLC13G/AOld format–––SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Hepion Pharmaceuticals, Inc. shares.

No Form 144 notices for Hepion Pharmaceuticals, Inc. are on file.